The majority of Ethiopian isolates carried the main marker for chloroquine (CQ) resistance, while the majority of the samples from Tanzania carried markers for CQ susceptibility.
artemisinin-combination therapy (ACT)
This study showed a high diversity of P. falciparum in northern Benin with a very low prevalence of resistance markers to CQ and SP that dramatically contrasted with the pattern observed in southern Benin.
While data on the anti-malarial market shows favourable progress towards replacing artemisinin monotherapies with ACT, the widespread use of drug cocktails to treat malaria is a barrier to effective case management.
Scaling-up effective malaria interventions reduced malaria-related burden at health facilities by over 75% within 5 years.
Process analysis of the treatment pathway for febrile children must be stratified by sector of treatment-seeking.